WELCOME TO GLOBAL MEDICINAL CANNABIS ACADEMIA

Global Medicinal Cannabis Academia is dedicated to providing internationally certified educational programs for knowledge exchange in the field of treatment, drug development, and international networking of key stakeholders in the field of medical cannabis. Our online academy offers a wide range of courses designed to empower individuals with the latest advancements and best practices in medicinal cannabis.

Director's Note

Records of medical cannabis treatment date back to 2737 BC, when the Chinese Emperor Shen,

in the Nung Pen Tsao Ching, recorded the use of cannabis for the treatment of inflammation, malaria and rheumatism, and also used it with wine as an anesthetic.

Our numerous and respected team advocates for the legal regulation of medical cannabis for therapeutic purposes worldwide and is one of the most recognizable and, above all, the most experienced global teams in the cannabis environment,

which visibly works tirelessly in its own local and international environment.

The Global Medicinal Cannabis Academia Team, respects the high principles of conventional and traditional natural medicine, existing international legislation, defends the rights of patients to natural treatment, operates with high ethical principles,

and belongs to the high international development of new approaches and natural medicines,

in connection with modern conventional medicine.

At the Global Academy of Medical Cannabis,

we are committed to fostering education and creating a community of physicians and experts in the field of medical cannabis.

Our online platform serves as a hub for the exchange of knowledge, experience, and development of cutting-edge medical cannabis innovations,

and creates a space for collaborative learning and professional growth.

Welcome to our community,

M.Sc. Majda Robić, Director of the Global Academy of Medical Cannabis with Team

Mission & Philosophy

Our mission is to provide knowledge in the field of acquiring professional knowledge and skills in the field of treatment and drug development in the field of medical cannabis at the highest international professional level.

We are committed to imparting professional knowledge with many years of experience, with which we promote the values of continuous learning, ethical medical, developmental and legal practices and global cooperation in the field of medical cannabis.

We believe in cultivating a culture of kindness, quality, respect, responsibility, hard work and enjoyment in all aspects of our educational initiatives with which we want to achieve maximum understanding of treatment, development and the latest approaches and legal options in the local and global field.

Medicinal Cannabis Competence

Meet
Global Medicinal Cannabis Academia
Team

Medicinal Cannabis

Senior professional lecturer & Doctor of Medicine

Dr. Kylie O’Brien, PhD

AUSTRALIA

Professor Kylie O'Brien is, Doctor of Chinese Medicine and Science (Chin Med), MPH, BAppSc (Chin Med), BSc (Optometry), Grad Cert Tertiary Education.

Trained originally as an optometrist, after 15 years in clinical practice Kylie career-changed to Chinese medicine (CM), developing a career as an academic in CM. She developed the curricula for three Master degrees in CM, and was the Course Coordinator for Victoria University’s undergraduate and Western Sydney University Masters courses in CM. Subsequent roles as Associate Dean (Teaching and Learning) at Victoria University, Director of Assessment and Learning Design (Deakin University), National Academic Director (AIAS), Director of Education (National Institute of Integrative Medicine) and Director of Education (Australasian College of Nutritional and Environmental Medicine) equipped her with a deep understanding and strong leadership skills in tertiary education. She entered the medicinal cannabis industry in 2018 and became one of Australia’s leading educators in this field. She is actively involved in clinical research into medicinal cannabis, and has authored three books: O’Brien and Sali, A Clinicians Guide to Integrative Medicine, Springer 2017; O’Brien and Blair, Medicinal Cannabis and CBD in Mental Healthcare, Springer 2021 and O’Brien and Bosak, Medicinal Cannabis in Women’s Health, Springer 2025. She is an Adjunct Professor at Torrens University and an Adjunct Associate Professor at NICM Health Research Institute, (Western Sydney University) and is a member of the Australian government’s TEQSA Expert Panel.

Medicinal Cannabis

Senior professional lecturer Doctor of Medicine

Dr. Philip W. Blair PhD

UNITED STATES OF AMERICA

COL Philip Blair, MD, graduated from West Point ’72, trained in Family Medicine, served as a combat physician in Gulf War and retired after 25 years. He managed complex diseases for 15 years and since 2014 he has been treating, consulting and lecturing on the endocannabinoid system and nonpsychoactive cannabidiol. [50] Dr. Philip Blair, MD, (Colonel USArmy) graduated from West Point ’72, was a combat physician and retired after 25 years. He managed complex diseases for 15 years and since 2014 has treated, consulted and lectured on the endocannabinoid system and cannabidiol from hemp. He has consulted with patients, parents and professionals worldwide about CBD. In 2021 he coauthored the Medicinal Cannabis and CBD in Mental Healthcare and developed BCPLus, a non-cannabis CB2R activator. (74w) Dr. Philip Blair, MD, (Colonel USArmy retired) is a Family Physician and consultant in disease management in the Northwest. He graduated from West Point 1972 and University of Miami School of Medicine 1978, trained in Family Medicine and served as combat physician in 1990-1991 Gulf War. After medical assignments in three continents and 25 years in uniform he retired from the Army and has been consulting on complex disease management. Since 2014 Dr. Blair has been studying, treating, writing and lecturing about cannabidiol and the human body’s natural endocannabinoid system (ECS). ECS dysfunction appears closely associated with the full range of chronic illness. His goal is to restore health and performance by enhancing the ECS through diet, exercise, appropriate medications and non-psychoactive herbs. In 2021 he coauthored the Medicinal Cannabis and CBD in Mental Healthcare and developed BCPLus, an oral non-cannabis CB2R activator from caryophyllene. [148w]

Medicinal Cannabis

Professional Lecturer & Researcher

Dr. Tina Mele

SLOVENIA - EU

Dr. Tina Mele is a Doctor of Veterinary Medicine and Doctor of Medical Sciences, an herbalist, a wise woman and one of the greatest experts in green natural medicine and the use of wild food.
She completed her doctoral dissertation at the Faculty of Medicine, in the field of Pharmacology. She presented her research on cannabis in the academic article "New indications and development of Cannabis - based medicines". Dr. Mele works as a professor of Biopsychology at the University of Primorska in Slovenia. She currently researches and lectures on professional topics such as the integration of herbal medicine in the environment of science and tradition, herbal medicine, medicine for people and scientific achievements, and she is a professional advocate for topics related to medical cannabis.

Madicinal Cannabis

Professional Researcher

Doc. Dr. Tanja Bagar

SLOVENIA - EU

Dr. Tanja Bagar is the director of the Icanna Institute and an assistant professor at Alma Mater Europaea - ECM.

She graduated in microbiology and later received a PhD in Biomedicine, majoring in Molecular Biology and Biochemistry, and has experience in clinical microbiology, research biotechnology, ecology, and teaching. She has been teaching microbiology and biochemistry and other ecological topics to students for many years.
She is interested in what happens in the microscopic cells of our body, how cells cooperate and communicate with each other, and also how external factors affect our body. From food and toxins to touch.

Cannabis in Medicine is a pioneering book by Dr. Tanja Bagar, with the authority of an established scientist in the field of biomedicine, convincingly presents the scientific foundations of the use of cannabis in medicine, where, through scientific facts about the functioning of the body at the cellular level, she explains to both laypeople and high-level professionals how the endocannabinoid system is expressed in the body and thus influences its functioning through risks, safe use and dosage.

Medicinal Cannabis

Senior Scientist

PhD Mikael Kowal (Netherlands)

NETHERLANDS -EU

Mikael Kowal has been working in the medicinal cannabis industry since 2014. He previously completed his PhD at Leiden University in the Netherlands on the topic of psychopharmacology of cannabis. Over the years Mikael has been involved in the conduct of several clinical trials with cannabis. More recently, he has been actively setting up an internal scientific research program. Mikael is interested in exploring the full medical potential of the cannabis plant, while acknowledging the limitations and risks of treatment with cannabis.

Medicinal Cannabis

Research Senior Professor

Cellular Neurobiology Laboratory

Pamela Maher, PhD

UNITED STATES OF AMERICA

Pamela Maher received her BSc from McGill University in Montreal, Quebec and her PhD from the University of British Columbia in Vancouver, British Columbia. She is currently a Research Professor and head of the Cellular Neurobiology Laboratory at The Salk Institute in La Jolla, CA. Her research interests include models and mechanisms of cell death in aging and neurodegenerative diseases with a specific focus on the oxytosis/ferroptosis regulated cell death pathway. In addition, she works on the characterization and development of natural products and derivatives thereof for the treatment of acute and chronic neurological disorders including Alzheimer's disease

Dr. Pamela Maher is searching for compounds that could slow or stop the progression of neurodegenerative diseases, with a focus on Alzheimer's disease. Her novel approach uses compounds derived from natural products such as strawberries, turmeric, and cannabis to treat the cellular aging and memory loss seen in Alzheimer's disease. Maher and her team discovered a new cell death pathway called oxytosis/ferroptosis and were among the first to consider aging in the discovery of drugs for Alzheimer's disease.

Medicinal Cannabis

Professional Development Researcher, Pharmacist, Faculty Lecturer and Publicist

Prof. Dr. Samo Kreft, Master of Pharmacy

SLOVENIA - EU

Prof. Dr. Samo Kreft is a full professor at the Faculty of Pharmacy of the University of Ljubljana, where he researches medicinal plants and other medicines of natural origin and lectures on them to students. He has also held professional positions at the European Medicines Agency in London. He has published more than 100 original scientific articles in renowned scientific journals. In addition to scientific articles, he has written more than 70 popular and professional articles and is a regular guest on television and radio shows. He was the editor of several books, such as Sodobna fitoterapija, which has already sold more than 3,000 copies; Food supplements, which was published by the reputable foreign publishing house Elsevier; Kvarkadabra in the kitchen; Ayurveda – a new way for healthy life in Europe …
He is interested in medicinal plants, primarily cannabis, because they intertwine the research fields of botany, chemistry, ecology, medicine, as well as ethnology and history. He is fascinated by the blurred boundaries between the researched and the unexplored, the proven and the traditional, the official and the alternative.

He is the editor of the website MODERN PHYTOTHERAPY .

Medicinal Cannabis & Hemp

Professional NGO Lobbyist,

International Medical Cannabis Law proponent,

Global Public Interest Law Advocate and

Strategic Leader of Global Projects

M.Sc. Majda Robić

SLOVENIA - EU

Before the European Parliament , the European Commission and the United Nations, as well as before numerous embassies, Ms. Robić Majda , as an international lobbyist and NGO representative and head of Slovenian, European and international projects, among other things, independently advocates for the importance of industrial hemp, cannabinoids and medical cannabis, in equal and professional interest. With her work team, she achieves key breakthroughs and global achievements that represent a key contribution to global development, economy and human and environmental health, also before 60 countries of the United Nations - UN, where she leads global negotiations and NGO lobbying for medical cannabis and CBD, where with the 2023 team, they reach a final key binding global agreement. In Slovenia, she leads the National Cannabis Working Team of the Republic of Slovenia, which, under her leadership, introduced legislation for the marketing, development and production of industrial hemp products and professionally participated in the establishment of the Cannabis for Medical and Scientific Purposes Act (ZKMZN).

For more than 15 years, she has been the president of the Pomurje Herbalists' Association in the public interest and is the executive director of WORLD HEMP CONGRESS, GLOBAL medicinal cannabis INNOVATIONS, GLOBAL HEMP INNOVATION, GLOBAL HEMP tech INNOVATON, GLOBAL HEMP food INNOVATION and GLOBAL green tech INNOVATIONS, and manages the Panonia Institute where she leads the PROJECT DEVELOPMENT NETWORK and other current projects.

M.Sc. Majda Robić, at the international master's level, completed the MicroMasters Certified International Master in EMA - Entrepreneurial Mind in Action in the Digital Age, which confirms her education in the field of innovation, management and preparation of international demanding projects and at the master's level, she is professionally oriented in Business Law and Lobbying in the EU, European Law, Law and Human Resources, International Economic Relations and Institutions and other broader business management development knowledge. He is upgrading his knowledge at Stanford Business University in the USA and is preparing for a doctorate in Politics and Diplomacy in Switzerland.

Medicinal Cannabis & Hemp

Senior international Lawyer

Charles Kovess, LL.B. (Hons), LL.M., CSP, KSJ

AUSTRALIA

Mr. Charles Kovess, graduated with honours in Law from the University of Melbourne and later obtained a Master of Laws from Monash University, has established himself as a formidable figure in the legal world. His expertise and leadership culminated in the establishment of his own law firm and later as head of the commercial law department at Barker Gosling in Australia, later specialising in medical and industrial cannabis law, and also advising organisations seeking to expand globally. From chairing the Australian-Hungarian Chamber of Commerce to contributing to various charities, his commitment to positive global impact is unwavering, as is his commitment to the cannabis sector, where he is involved in drafting Australian and international legislation in the field, developing innovation and embedding cannabis into the economic and social life of Australia and globally. He is currently the President of the Australian Industrial Hemp Association, a member of the Executive Committee of the Federation of International Hemp Organizations and an invaluable member and expert at the WORLD HEMP CONGRESS.

Kovess, today, among other things, represents one of the most prominent global business, development, ethical and investment public promoters and motivators,
where he works in the recently world-class company Kovess International

WELCOME TO GLOBAL MEDICINAL CANNABIS ACADEMIA

Director's Note

Mission & Philosophy

Meet Global Medicinal Cannabis Academia Team

Meet
Global Medicinal Cannabis Academia
Team